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ABSTRACT
Background We wanted to clarify whether preopera-
tive magnetic resonance imaging (MRI) in the clinical 
setting can evaluate the pathologic pseudocapsule (PC) 
morphology with high accuracy in renal cell carcinoma 
(RCC).
Methods We retrospectively analyzed 34 consecu-
tive patients who underwent MRI (1.5 or 3.0T, 5 mm 
slices) prior to partial nephrectomy (PN) for RCC at 
our institution between January 2010 and December 
2019. First, the correlation between PC morphology 
(complete or incomplete) and tumor infiltration to the 
renal parenchyma was examined as pathologic valida-
tion. Second, the concordance rate of PC morphology 
between pathologic tissue and preoperative MRI was 
evaluated as radiologic validation. Third, risk factor for 
renal parenchymal invasion in RCC was analyzed.
Results In the pathologic validation, parenchymal 
invasion rates were 11% and 28% in the “complete PC” 
and “incomplete PC” groups, respectively. In the radio-
logic validation, pathological PC morphology could be 
diagnosed on preoperative MRI in 17 patients (50.0%). 
“None PC” on MRI had the lowest positive predictive 
value (PPV) (0%), “partial PC” on MRI had a good 
PPV (76.5%), “complete PC” on MRI had a relatively 
low PPV (33.3%). Unfortunately, these data were insuf-
ficient for diagnostic accuracy. As risk factor for renal 
parenchymal invasion in RCC, only pathologic subtype 
(non-clear cell) was found to have significant differences 
in the multivariate analysis.
Conclusion The results of this study suggest that renal 
tumors with pathologically incomplete PC have a high 
possibility of renal parenchymal invasion. However, it is 
currently difficult to accurately evaluate pathologic PC 
morphology by preoperative MRI in the clinical setting.
Key words renal cell carcinoma; pseudocapsule; renal 
parenchymal invasion; preoperative magnetic resonance 
imaging; partial nephrectomy
Pseudocapsule (PC) is an interstitial fibrous capsule 
that forms around renal cell carcinoma (RCC) and is 
considered to occur secondarily following inflammatory 
reaction due to displacement of healthy renal paren-
chyma by tumor. The PC is usually ≤ 2.5 mm thick, and 
in the case of incomplete loculation, tumor invasion can 
be observed into the interstitium of the capsule and into 
renal parenchyma beyond the capsule.1–3,
Partial nephrectomy (PN) for small RCC is as 
effective as radical nephrectomy (RN) in controlling 
cancer and reduces the likelihood of cardiovascular 
events.4–7 Therefore, PN has become the gold standard 
procedure specifically for treating T1a RCC having a 
tumor diameter of ≤ 4 cm.8 In recent years, good treat-
ment outcomes have been reported sporadically in T1b 
RCC, mainly at high-volume centers, leading to a trend 
of expanding indications for PN.9–11
However, positive surgical margin (PSM) in PN 
have been reported to occur at a rate of 4.9%–8.1% in 
laparoscopic PN and 0%–8.7% in robotic-assisted PN.12 
In addition, multiple recent studies have reported that 
tumor enucleation (TE) is as effective as standard PN in 
controlling cancer and preserving renal function.13–15 
Given that the TE technique involves the incision of PC 
that has formed around the renal tumor along the renal 
parenchyma, this procedure is advantageous in terms 
of decreasing hemorrhage volume. However, it must 
be taken into account that there is some probability of 
PSM. Wang et al. compared 59 patients who underwent 
TE with 58 patients who underwent PN, and reported 
that the TE patients had less hemorrhage volume and 
fewer postoperative complications than those in the PN 
patients; however, PSM was significantly more frequent 
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in the TE patients than in the PN patients (17.2% vs 
0%).16 Numerous studies of the influence of PSM on 
prognosis have reported that PSM did not affect cancer-
specific survival or overall survival (OS),17, 18 but 
several studies have reported PSM as a poor prognostic 
factor for OS. Shum et al. analyzed 20,762 patients who 
underwent PN for T1/T2N0M0 RCC using propensity 
score matching, and reported that PSM, old age, high 
Charlson Comorbidity Index, and large tumor size 
were poor prognostic factors for OS.19 In this regard, 
these findings remain controversial, and PSM should be 
avoided as much as possible in any case.
In the actual PN procedure, PC is excised with 
some normal renal parenchyma outside the PC, aiming 
to secure a safety margin. However, it is currently im-
possible to rule out tumor invasion beyond the PC either 
by preoperative imaging or based on the intraoperative 
findings, which contributes to the occurrence of PSM. 
If tumor invasion beyond the PC could be evaluated 
accurately on preoperative imaging, it may become pos-
sible to effectively avoid PSM by setting a thick safety 
margin at the invasion site.
Papalia et al. investigated tumor invasion into the 
PC in pathological tissues (i–Cap score) and in preoper-
ative MRI images (MRI–Cap score) in 58 patients who 
underwent PN and examined the degree of concordance 
between them. Overall, concordance was observed in 
50/58 patients (86%). Regarding the concordance by 
score, AUC was 0.86–0.96, which indicates highly ac-
curate diagnostic performance.20 However, the MRI pa-
rameters (3.0T, 2–3 mm slices) used in their study were 
different from those in daily clinical use. Meanwhile, 
Cho et al. examined the correlation between tumor inva-
sion into the PC and the pathological morphology of PC 
in 161 patients who underwent PN or RN. Their results 
showed that 94 patients (58.4%) had complete capsule, 
62 patients (38.5%) had incomplete capsule, and 5 
patients (3.1%) had no capsule. In addition, PC invasion 
and renal parenchymal invasion were observed in 58 
(36.0%) and 47 (29.2%) patients, respectively. They 
reported the following as significant risk factors for 
renal parenchymal invasion: histologic diameter greater 
than ≥ 4 cm, non-clear cell histology, and incomplete 
PC. They concluded that “surgeons must prepare for the 
possibility of a positive surgical margin if a tumor has at 
least one of these risk factors”.21 However, “incomplete 
PC” in their study was diagnosed pathologically; hence, 
preoperative determination was impossible.
Accordingly, we hypothesized that even though 
preoperative MRI in the clinical setting cannot be 
evaluated for minimal tumor invasion into the renal 
parenchyma, if a combination of the methods of Papalia 
et al. and Cho et al. could be used to evaluate whether 
the PC morphology is “complete” or “incomplete” with 
high accuracy, could be applied to PN procedure.
MATERIALS AND METHODS
Study population
This study was approved by the Ethics Committee of 
Tottori University, Japan (approval number 20A019). We 
retrospectively analyzed 34 consecutive patients who 
underwent MRI prior to PN for RCC at our institution 
with negative surgical margin between January 2010 
and December 2019. First, the correlation between 
PC morphology and tumor infiltration to the renal 
parenchyma was examined as pathologic validation, 
according to methods of Cho et al. Second, the rate of 
concordance of PC morphology between pathological 
tissue and preoperative MRI was evaluated as radiologic 
validation. Third, the risk factors for renal parenchymal 
invasion were analyzed.
Pathologic assessment
Pathologic assessment was performed by two uropathol-
ogists. If their evaluations of a single sample differed, 
they consulted to decide on a single answer. All patho-
logical tissues were step-sectioned at 5 mm intervals 
centering on the maximum split surface of the tumor, 
entirely embedded in paraffin blocks, and stained with 
hematoxylin and eosin for microscopic examination. 
Moreover, in areas in which renal parenchymal invasion 
was suspected macroscopically, sections were created in 
that area and evaluated.
Radiologic assessment
Image assessment was carried out by two radiologists 
with more than 10 years of experience. If their evalu-
ations of a single sample differed, they consulted to 
decide on a single answer. MRI was performed using a 
1.5T MR systems (Achieva; Philips Medical Systems, 
Best, Netherlands) or 3.0T MR system (Skyra; Siemens 
Health Care, Erlangen, Germany). T2–weighted images 
(TR, 600 ms; TE, 82 ms; section thickness, 5 mm; 
intersection gap, 1.0 mm; acquisition time, 17–20 sec) 
were obtained in the axial, coronal, and sagittal planes. 
T1–weighted images (TR, 140 ms; TE, 2.5 ms; section 
thickness, 5 mm; intersection gap, 1.0 mm; acquisition 
time, 15 sec) were obtained in the axial and coronal 
planes. Diffusion-weighted images were obtained in the 
axial plane during free breathing. Imaging parameters 
for DW imaging were as follows: TR, 1800 ms; TE, 65 
ms; inversion time, 200 ms; b factors, 0-50-800 s/mm2; 
160 × 62 matrix; field of view, 380 mm; section thick-
ness, 5 mm; intersection gap, 1.0 mm; acquisition time, 
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2–3.5 min. The choice of MRI device was made based 
on scanner availability rather than by any set criteria.
Definition of PC
Regarding pathological definition of PC, the definitions 
used in the study of Cho et al. were adopted in the pres-
ent study. A peritumoral PC was defined as a parallel 
band of fibrocollagenous connective tissue located at 
the interface of the tumor and adjacent normal renal pa-
renchyma that could be verified on Masson’s trichrome 
staining; and further subdivided as “intrarenal” or “ex-
trarenal”. We focused on “intrarenal PCs”, as defined by 
Azhar et al., and “PCs on the parenchymal kidney side” 
as defined by Minervini et al., and excluded “extrarenal 
PCs” and “PCs on the perirenal adipose tissue side” 
from our analysis.1, 2, 21 Cho et al. recommend Masson’s 
trichrome staining for visualization of PC, but in this 
study, we did not add Masson’s trichrome staining 
because hematoxylin and eosin staining alone was suf-
ficient to evaluate PC.
In addition, regarding radiological definition of 
PC, PC was defined as a thin linear regular hypointense 
band surrounding the tumor on T2- and T1-weighted 
images, as with the study of Papalia et al.20
Definition of PC morphology (completeness of PC)
The definitions used in the study of Cho et al. were 
adopted in the present study. A PC was regarded as 
“complete” if it was intact without disconnection along 
its whole length despite any narrowing of width. A 
PC was regarded as “partial (incomplete)” if any areas 
showed a disconnection from well-defined PC without 
parenchymal invasion. A completeness of PC classifica-
tion of “none” was defined as a PC that was not visible 
at any point along the whole tumor length, such that 
the neoplastic cells directly interfaced with the renal 
parenchyma without any fibrous band (Fig. 1).21
Definition of parenchymal invasion of PC
The definitions used in the study of Cho et al. were ad-
opted in the present study. A classification of “free from 
invasion” was defined as a state in which the PC was 
intact and had no signs of infiltration of neoplasm along 
the entire PC length regardless of the completeness of 
Fig. 1. Definition of completeness of pseudocapsule (PC). (a) 
“complete PC” was intact without disconnection along its whole 
length despite any narrowing of width. (b) “partial (incomplete) 
PC” certain areas showed a disconnection of well-defined PC 
without parenchymal invasion. (c) “none PC” was not visible at 
any point along the whole tumor length, and the neoplastic cells 
directly interfaced with the renal parenchyma without any fibrous 
band. P = pseudocapsule; T = tumor; R = renal parenchyma. Bar 
= 200 μm.
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PC. “Partial invasion” was defined as entrapment or 
sequestration of tumor cells in the PC, without invasion 
beyond the PC. “Parenchymal invasion” was defined as 
neoplastic invasion into the renal parenchyma beyond 
the PC.21
Statistical analysis
All statistical analyses were performed using IBM SPSS 
Statistics 25 (IBM, Armonk, NY). Kappa coefficient 
was used to test concordance between pathologic assess-
ment and radiologic assessment. Fisher’s exact test was 
used to compare categorical variables, Mann–Whitney 
U test was used for non-parametric comparisons of 
continuous variables, and multivariate Cox regression 
analysis was used to evaluate the impact of each vari-




Table 1 shows the demographics of the 34 patients. The 
median age was 71 years old. Of the 34 patients, 24 
(70.6%) were men. The median tumor diameter was 
22.5 mm. Most of tumors were classified as T1a (94.1). 
Regarding pathologic subtypes, clear-cell carcinoma 
was observed in 26 patients (76.4%), papillary carcino-
ma in 2 patients (5.9%), and chromophobe carcinoma in 
2 cases (5.9%). The median RENAL nephrometry score 
was 7. Regarding pathological completeness of PC, 
“Complete” was observed in 9 patients (26.4%), “Partial” 
in 23 patients (67.7), “None” in 2 patients (5.9%). There 
were 11 patients had free from invasion (32.4%), 15 had 
partial invasion (44.1%), and 8 had parenchymal inva-
sion (23.5%).
Pathologic validation
Table 2 shows the ratio of pseudocapsular invasion in 
each PC morphology, of 9 “complete” group, 33% had 
free from invasion, 56% had partial invasion and 11% 
had parenchymal invasion. Of 23 “partial” group, 30% 
had free from invasion, 44% had partial invasion and 
26% had parenchymal invasion. Of the 2 “none” group, 
50% were had free from invasion group and 50% had 
parenchymal invasion. The parenchymal invasion rates 
were 11% and 28% in “complete” and “partial + none” 
group, respectively, showing no statistically significant 
differences between them (P = 0.40).
Radiologic validation
Tables 3 and 4 show the degree of concordance between 
pathologic assessment and radiologic assessment. Of 34 
patients, 17 (50%) were able to diagnose pathological 
Table 1. Patient demographics
n = 34
Median age, years (IQR) 71 (48–90)
Male / Female (%) 24 / 10 (70.6 / 29.4)
Median tumor diameter, cm (IQR) 22.5 (11–65)
Pathologic stage
 pT1a (%) 32 (94.1)
 pT1b (%) 2 (5.9)
Pathologic subtypes
 Clear cell (%) 26 (76.4)
 Papillary (%) 2 (5.9)
 Chromophobe (%) 2 (5.9)
 Other (%) 4 (11.8)
Fuhrman grade
 Grade 1 (%) 5 (14.7)
 Grade 2 (%) 23 (67.7)
 Grade 3 (%) 6 (17.6)
 Grade 4 (%) 0 (0)
Median R.E.N.A.L score (IQR) 7 (4–10)
(R)adius
 ≤ 4 cm 32 (94.1)
 4 < and ≤ 7 cm 2 (5.9)
 7cm ≤ 0 (0)
(E)xophytic properties
 Exophytic ≥ 50% 10 (29.4)
 Exophytic < 50% 20 (58.8)
 Entirely endophytic 4 (11.8)
(N)earness to the sinus
 7mm < 14 (41.2)
 4 < and ≤ 7 mm 7 (20.6)
 ≤ 4mm 13 (38.2)
(A)nterior or posterior
 Anterior 10 (29.4)
 Posterior 17 (50.0)
 Axial 7 (20.6)
(L)ocation
 Above 17 (50.0)
 Cross 10 (29.4)
 Axial midline 7 (20.6)
Pathological PC morphology (completeness of PC)
 Complete 9 (26.4)
 Partial 23 (67.7)
 None 2 (5.9)
Pseudocapsular invasion
 Free from invasion 11 (32.4)
 Partial invasion 15 (44.1)
 Parenchymal invasion 8 (23.5)
IQR, interquartile range.
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PC morphology by MRI (Table 3). Of the 5 cases deter-
mined to have “none PC” by MRI, three were pathologi-
cally “partial PC” and two were “complete PC”. On the 
other hand, Of the 12 cases determined to have “complete 
PC” by MRI, Seven were pathologically “partial PC” 
and one was, surprisingly, “none PC”. Sensitivity, 
specificity, positive predictive value (PPV), and positive 
predictive value (NPV) of whether preoperative MRI 
could be used to assess pathological PC morphology are 
shown in Table 4. As for sensitivity, the accuracy for 
“none PC” was the lowest at 0% and “partial PC” was 
the highest at 56.5%. As for specificity, the accuracy for 
“partial PC” was the lowest at 63.6% and “none PC” 
was the highest at 84.4%. None PC on MRI had the 
lowest PPV (0%), but the highest NPV (93.1). Partial PC 
on MRI had a good PPV (76.5%), but a relatively low 
NPV (41.2%). Complete PC on MRI had a relatively low 
PPV (33.3%), but a good NPV (77.3%).
Risk factor for parenchymal invasion
In the univariate analysis, significant differences were 
observed in pathologic subtype (non-clear cell), total 
RENAL score (7 points or more), location (cross) and 
Fuhrman grade (G3 or higher). However, only patholog-
ic subtype (non-clear cell) was found to have significant 
differences in the multivariate analysis (Table 5).
DISCUSSION
The purpose of this study was to investigate whether 
preoperative MRI in the clinical setting can evaluate 
the PC morphology (complete or incomplete) with high 
accuracy and to prove that our hypothesis was correct. 
In Western countries, MRI is not commonly performed 
as a preoperative examination for PN because of its 
expensiveness. However, if our hypothesis proves to be 
correct, it may be possible to reduce PSM by adjusting 
the surgical margin during PN, thus increasing the 
Table 2. The ratio of pseudocapsular invasion in each PC morphology in the pathologic validation
Pathologic PC morphology
Complete Partial None
(n = 9) (n = 23) (n = 2)
Pseudocapsular invasion
Free from invasion (%) 3 (33) 7 (30) 1 (50)
Partial invasion (%) 5 (56) 10 (44) 0 (0)
Parenchymal invasion (%) 1 (11) 6 (26) 1 (50)
PC, pseudocapsule.
Table 3. Concordance between pathologic assessment and radiologic assessment of PC morphology
PC morphology Radiologic (MRI) assessment
None Partial Complete Total
Pathologic  
assessment
None 0 1 1 2
Partial 3 13 7 23
Complete 2 3 4 9
Total 5 17 12 34
MRI, magnetic resonance imaging; PC, pseudocapsule.
Table 4. ensitivity, specificity, PPV, NPV of radiologic (MRI) assessment compared to pathologic assessment
MRI / Pathologic 
None PC
MRI / Pathologic 
Partial PC
MRI / Pathologic 
Complete PC
Sensitivity 0 (0/2) 56.5 (13/23) 44.4 (4/9)
Specificity 84.4 (27/32) 63.6 (7/11) 68.0 (17/25)
PPV 0 (0/5) 76.5 (13/17) 33.3 (4/12)
NPV 93.1 (27/29) 41.2 (7/17) 77.3 (17/22)
MRI, magnetic resonance imaging; NPV, negative predictive value; PC, pseudocapsule; PPV, positive predictive value.
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usefulness of MRI as a preoperative examination. To 
confirm these, we conducted a step-by-step investiga-
tion of pathologic validation, radiological validation and 
risk factor for parenchymal invasion.
First, as pathologic validation, we investigated the 
relationship between PC morphology and renal paren-
chymal invasion in accordance with the report of Cho et 
al.21 Although we found no significant differences, the 
proportion of renal parenchymal invasion was higher 
in patients with either “partial PC” or “none PC” than 
in patients with “complete PC”. The reason why there 
were no significant differences may be the small num-
ber of patients. When we consider that PC is formed by 
inflammation as a protective reaction by healthy renal 
parenchyma against tumor, the finding of the higher 
proportion of renal parenchymal invasion in patients 
with incomplete PC is not theoretically contradictory. 
Therefore, we proceeded to radiological validation.
Second, as radiological validation, we classified the 
morphology of PC based on preoperative MRI, as re-
evaluated by two radiologists, and evaluated the diag-
nostic accuracy for pathologic PC morphology. Overall, 
we were able to diagnose pathologic PC morphology 
with a probability of 50% using preoperative MRI, 
however it was insufficient for diagnostic accuracy. 
Moreover, the sensitivity and PPV for “none PC” by 
MRI were both 0%, which means that it was very dif-
ficult to prove the absence of PC (Fig. 2a). Similarly, the 
sensitivity and PPV for “complete PC” by MRI were 
both less than 50%, which means that it was very dif-
ficult to prove that the thickness of PC was completely 
uniform. On the other hand, the sensitivity and PPV for 
“partial PC” by MRI were relatively good, suggesting 
that the presence of PC of non-constant thickness was 
easy to read. However, no certain standard was obtained 
as to what thickness could identify the presence of PC 
on MRI. In fact, pathological “none PC” was included 
in the cases that were judged as “partial PC” or “complete 
PC” on MRI, suggesting that there are other causes 
for reading as PC other than the actual presence of PC 
(Fig. 2b). One of the reasons for the lack of sufficient 
diagnostic accuracy in the present study was assumed 
to be the small number of cases that were taken by 3.0T 
MRI. In fact, only five patients underwent MRI at 3.0T 
and 19 patients (approximately 85%) underwent MRI 
at 1.5T due to the limited number of 3.0T MRI systems 
in our institution. If all patients had been scanned at 
3.0T with 5 mm slice thickness, the diagnostic accuracy 
could have been much improved. However, we would 
like to emphasize that the present study aimed to clarify 
the diagnostic accuracy of MRI technique as used in 
daily clinical setting. In other words, at present, it is 
somewhat difficult to discriminate pathological PC 
morphology with preoperative MRI technique in daily 
clinical setting.
Third, Minervini et al. retrospectively analyzed 90 
patients who underwent TE in a study of risk factors 
for renal parenchymal invasion, and observed tumor 
Table 5. Risk factor for parenchymal invasion
Univariate Multivariate
Factors P value OR (95% CI) P value
Age 0.221 – –
Karnofsky performance status 0.323 – –
Tumor diameter 0.343 – –
Preoperative hemoglobin 0.475 – –
Preoperative neutrophil cell 0.985 – –
R.E.N.A.L score (7 ≤ vs 7) 0.047 2.50 (0.08–79.6) 0.604
 (R)adius (4 cm < vs ≤ 4 cm) 1.000 – –
 (E)xophytic properties (50% ≤ vs < 50%) 0.390 – –
 (N)earness to the sinus (≤ 7 mm vs 7 mm <) 0.101 – –
 (A)nterior or posterior (AP vs X) 1.000 – –
 (L)ocation (cross vs above) 0.018 7.64 (0.39–150.0) 0.389
Pathologic subtypes (non-clear vs clear) < 0.001 22.54 (1.23–413.6) 0.036
Fuhrman grade (G3 vs G1-2) 0.016 2.01 (0.11–38.6) 0.642
PC morphology (partial+none vs complete) 0.402 – –
CI, confidence interval; OR, odds ratio; PC, pseudocapsule.
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invasion of PC in 30 patients (33.3%), of whom 11 
(12.2%) had tumor invasion within the PC alone, 13 
(14.4%) had renal parenchymal invasion beyond the PC 
and 6 (6.6%) had PC penetration on the perirenal fat 
tissue. In addition, they reported tumor diameter and 
Fuhrman grade 3 as risk factors for invasion of PC.2 As 
mentioned above, Cho et al. reported histologic diameter 
≥ 4 cm, non-clear cell histology, and incomplete PC as 
the risk factors for renal parenchymal invasion.21 In our 
evaluation, a multivariate analysis revealed only RCC 
subtype (non-clear cell) as a risk factor. The absence of 
significant difference for tumor diameter may be due 
to the small number of patients with T1b (two patients). 
Comprehensive interpretation of these findings indi-
cated that risk could be determined preoperatively in 
patients with tumor diameter ≥ 4 cm or suspected non-
clear cell on preoperative imaging.
In the present study, our hypothesis was rejected. 
However, if these results were to be applied to PN 
procedure, they could be summarized as follows. Since 
there is a high possibility that there is a small amount 
of PC even in areas that appear to have no PC on MRI 
images, there is no need to leave an extreme amount of 
safety margin. However, there is always a risk of PSM 
in TE technique because there is a slight possibility that 
there is no PC even in areas that appear to have PC on 
MRI images. In practice, in terms of avoiding PSM, 
it seems reasonable to always leave a few millimeters 
of safety margin, regardless of the PC morphology. In 
addition, in patients with tumor diameter ≥ 4 cm or 
suspected non-clear cell on preoperative imaging, more 
adequate safety margin should be left.
This study has some limitations. First, it was a 
small-scale retrospective study. Second, we did not 
consider the characteristics of large-diameter tumors, 
for the reason that this study was restricted to patients 
who underwent partial nephrectomy and thus included 
only a few patients with tumor size > 4 cm. Third, for 
the reason mentioned above, the number of patients 
scanned with 3.0T MRI was small. Considering these 
limitations, it is necessary to conduct further studies 
with large numbers of patients.
In conclusion, the findings of the present study 
suggest that renal tumors with pathologically incom-
plete PCs have a high possibility of renal parenchymal 
invasion. However, it is currently difficult to accurately 
evaluate PC morphology by preoperative MRI in the 
clinical setting. Therefore, it is not practical to adjust 
the thickness of the safety margin during PN procedure 
based on the PC morphology by preoperative MRI to 
avoid PSM.
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